Header Logo

Connection

SHALINI MAKAWITA to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications SHALINI MAKAWITA has written about Antibodies, Monoclonal, Humanized.
SHALINI MAKAWITA
Connection Strength
0.036
Antibodies, Monoclonal, Humanized
  1. Phase II Study of Ramucirumab in Advanced Biliary Tract Cancer Previously Treated By Gemcitabine-Based Chemotherapy. Clin Cancer Res. 2022 06 01; 28(11):2229-2236.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.